ND-011992
ND-011992 is a reversible, selective quinazoline-type inhibitor targeting quinone reductases and quinol oxidases. ND-011992 inhibits respiratory complex I and bo3 oxidase in addition to bd-I and bd-II oxidases in E. coli strain BL21*Δcyo with the IC50 of 0.12, 2.47, 0.63 and 1.3 μM, respectively. ND-011992 can be used for tuberculosis study[1].
Product Specifications
CAS Number
2446880-46-0
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
Bacterial; Mitochondrial Metabolism
Type
Reference compound
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/nd-011992.html
Purity
98.26
Solubility
DMSO : 40 mg/mL (ultrasonic; adjust pH to 4 with 1 M HCl)
Smiles
FC(F)(F)C(C=C1)=CC=C1OC(C=C2)=CC=C2NC3=NC=NC4=CC=CC=C43
Molecular Formula
C21H14F3N3O
Molecular Weight
381.35
Precautions
H302, H315, H319
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
E Cadherin (CDH1) (NM_004360) Human Over-expression Lysate
AMACR / p504S (Prostate Cancer Marker) (AMACR/2748R), CF488A conjugate, 0.1mg/mL
Human AGR2 (Anterior Gradient Protein 2) ELISA Kit